Recurrent Lymphoma Active Not Recruiting Phase 1 Trials for Selinexor (DB11942)

IndicationStatusPhase
DBCOND0073930 (Recurrent Lymphoma)Active Not Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02323880Selinexor in Treating Younger Patients With Recurrent or Refractory Solid Tumors or High-Grade GliomasTreatment